Arkansas § 20-16-1505 Reporting

Arkansas Statutes

§ 20-16-1505 — Reporting

Arkansas § 20-16-1505

Title20

This text of Arkansas § 20-16-1505 (Reporting) is published on Counsel Stack Legal Research, covering Arkansas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Ark. Code Ann. § 20-16-1505 (2026).

Text

(a)If a physician provides an abortion-inducing drug to another for the purpose of inducing an abortion as authorized in § 20-16-1504 and if the physician knows that the woman who uses the abortion-inducing drug for the purpose of inducing an abortion experiences an adverse event, the physician shall provide a written report of the adverse event within three (3) days of the event to the United States Food and Drug Administration via the MedWatch program reporting system and to the Arkansas State Medical Board.

(b)(1) The board shall compile and retain all reports it receives under this section.

(2)(A) All reports received by the board are public records open to inspection under the Freedom of Information Act of 1967, § 25-19-101 et seq.

(B)The board shall not release to any person or e

Free access — add to your briefcase to read the full text and ask questions with AI

(a) If a physician provides an abortion-inducing drug to another for the purpose of inducing an abortion as authorized in § 20-16-1504 and if the physician knows that the woman who uses the abortion-inducing drug for the purpose of inducing an abortion experiences an adverse event, the physician shall provide a written report of the adverse event within three (3) days of the event to the United States Food and Drug Administration via the MedWatch program reporting system and to the Arkansas State Medical Board. (b) (1) The board shall compile and retain all reports it receives under this section. (2) (A) All reports received by the board are public records open to inspection under the Freedom of Information Act of 1967, § 25-19-101 et seq. (B) The board shall not release to any person or entity the name or any other personal identifying information regarding a person who: (i) Uses an abortion-inducing drug to induce an abortion; and (ii) Is the subject of a report received by the board under this section.